/Investor DB

Fidelity Investments

Institutional investor

Boston · 1 people tracked

Also known as FIAM LLC · FIDELITY DIVERSIFYING SOLUTIONS LLC · FIDELITY INSTITUTIONAL WEALTH ADVISER LLC · FIDELITY MANAGEMENT & RESEARCH COMPANY LLC · STRATEGIC ADVISERS LLC

Find your way into Fidelity Investments

Sign up to see every warm intro you have to Fidelity Investments

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Fidelity Investments team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Fidelity Investments is a U.S.-based diversified financial services company whose stated mission is to help customers and clients achieve their financial objectives.

Source: firm website, verified Sep 29, 2026.

HQ
Boston, MA, US
Founded
1946
Last 12 months
21 investments
AUM
$5.7T
Tracked investments
136
Unicorns
38
IPOs
23
Acquisitions
5

Team · 1 people

from public directories
Karen Melhart· Investorin

59 people who came through Fidelity Investments went on to found or lead other companies.

+ 47 more →

What they invest in

from 126 of 136 portfolio companies

Biotech ×43Healthtech ×36AI & Machine Learning ×35Deep Tech ×23Enterprise Software ×23SaaS ×22Medical Devices ×20Fintech ×16

HQs:United States×99Canada×3United Kingdom×2Belgium×1Brazil×1Cyprus×1

Investments · 136 tracked

founders shown can be your intro path

By year:2026 · 192025 · 192024 · 82023 · 52022 · 92021 · 162020 · 42019 · 22018 · 42017 · 52016 · 32015 · 6100 dated

Adagio TherapeuticsNASDAQ: IVVDApr 2021 · $336M

Invivyd develops monoclonal antibody therapies to prevent and treat serious viral infections, beginning with COVID-19 and expanding to respiratory syncytial virus and measles.

BiotechWaltham, US

Tillman U. Gerngross(Executive Officer, Director)Lynn Connolly(Executive Officer)Eric Kimble(Executive Officer)inHalley Gilbert(Executive Officer)Rebecca Dabora(Executive Officer)inEllie Hershberger(Executive Officer)

Co-investorsGV (Google Ventures)Foresite CapitalMithril Capital ManagementOmega FundsOrbiMedPolaris Partners+3 more

Atara Biotherapeuticsatarabio.comin𝕏NASDAQ: ATRA

Atara Biotherapeutics develops allogeneic T-cell immunotherapies using its proprietary EBV T-cell platform to harness the immune system for treating disease.

BiotechHealthtechMedical DevicesThousand Oaks, US

AnhCo Nguyen(President and Chief Executive Officer)Isaac Ciechanover(Founder)

Co-investorsDag VenturesEcoR1 CapitalHEALTHCARE ROYALTY PARTNERSKleiner PerkinsDomain Associates

Cerebras Systemscerebras.aiin𝕏NASDAQ: CBRSSep 2025 · $1.1B

Cerebras designs and manufactures wafer-scale AI processors and systems for data centers, enabling high-speed AI training and inference workloads.

AI & Machine LearningDeep TechHardwareSemiconductorsSunnyvale, US

Andrew Feldman(Founder)inGary Lauterbach(Founder)inMichael James(Founder)inSean Lie(Founder)inJean-Philippe Fricker(Founder)in

Co-investors2080 VenturesAlpha Wave GlobalArtisanal VenturesAurum Venture PartnersAzure Ventures GroupB Capital+46 more

Clarivateclarivate.comin𝕏NYSE: CLVT

Clarivate is a global provider of enriched data, insights, analytics, workflow solutions and expert services serving academia, government, intellectual property, and life sciences sectors.

BiotechData & InfrastructureEdTechEnterprise SoftwareHealthtechSaaS

Matti Shem Tov(Chief Executive Officer)in

Co-investorsLeonard GreenACE & CompanyT. Rowe Price

DoorDashdoordash.comin𝕏NASDAQ: DASH

DoorDash operates a restaurant delivery platform that connects customers with dining establishments across hundreds of cities in North America through a logistics network.

ConsumerE-commerceFoodTechLogistics & Supply ChainMarketplacesSan Francisco, US

Tony Xu(CEO)inAndy Fang(Founder)inStanley Tang(Founder)inEvan Moore(Founder)inRavi Inukonda(Chief Financial Officer)inPrabir Adarkar(Chief Operating Officer and President)in

Co-investorsA*Blue Owl CapitalBoxGroupBrave CapitalCoatue ManagementCRV (Charles River Ventures)+38 more

Fate Therapeuticsfatetherapeutics.comNASDAQ: FATE

Fate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Christian Weyer(Executive Officer, Director)J. Scott Wolchko(Executive Officer)Daniel Shoemaker(Executive Officer)inBahram (Bob) Valamehr(President & Chief Executive Officer)in

BoardAmir Nashat(Director)inJohn Mendlein(Director)

Co-investorsSanofi VenturesVenrockOVP Venture PartnersPolaris Partners

Figmafigma.comin𝕏NYSE: FIG

Figma is a collaborative design platform that enables teams to create apps, websites, and products through shared design tools integrated with development workflows and AI-powered design assistance.

Developer ToolsSaaSSan Francisco, US

Evan Wallace(Founder)Dylan Field(Founder)inPraveer Melwani(Chief Financial Officer & Treasurer)inKris Rasmussen(Chief Technology Officer)inShaunt Voskanian(Chief Revenue Officer)inBrendan Mulligan(General Counsel & Secretary)in

Co-investors137 Ventures1435 Capital1517AirAngelsAlkeon InnovationAmplify.LA+58 more

Instacartinstacart.comin𝕏NASDAQ: CARTMar 2021

Instacart operates a marketplace connecting grocery retailers with customers who order food and household items for same-day delivery or in-store pickup, serving millions of households across North America through partnerships with over 350 retailers.

ConsumerE-commerceFoodTechSan Francisco, US

Apoorva Mehta(Chairman \u0026 Founding CEO)inBrandon Leonardo(Founder)inMax Mullen(Founder)inChris Rogers(Chief Executive Officer)inEmily Reuter(Chief Financial Officer)inHetong Li(Senior Software Engineer)

Co-investorsA*Andreessen HorowitzAvenue Growth PartnersBACKGROUND CAPITALBling CapitalBright Pixel Capital+54 more

Intellia Therapeuticsintelliatx.comin𝕏NASDAQ: NTLAAug 2015

Intellia Therapeutics develops in vivo and ex vivo CRISPR/Cas9 gene editing therapies aimed at treating the root causes of severe genetic diseases, with lead candidates for hereditary angioedema and ATTR amyloidosis.

BiotechDeep TechHealthtechCambridge, US

Nessan Bermingham(Founder)inJennifer Doudna(Founder)Jose Rivera(Executive Officer)inJohn Leonard(President and Chief Executive Officer)inJames Basta(Executive Vice President, General Counsel and Corporate Secretary)inEdward Dulac(Executive Vice President, Chief Financial Officer)in

Co-investorsage1Atlas VentureAvoro Capital AdvisorsEcoR1 CapitalForesite CapitalOrbiMed+1 more

Lyftlyft.comin𝕏NASDAQ: LYFTJun 2018

Lyft is an on-demand ridesharing platform that connects passengers with drivers for various ride types, including standard rides, premium options, and other transportation services.

ConsumerEnterprise SoftwareMarketplacesMobility & TransportationSaaSSan Francisco, US

Logan Green(Founder)inJohn Zimmer(Founder)inDavid Risher(Chief Executive Officer)inErin Brewer(Chief Financial Officer)Lindsay Llewellyn(Chief Legal and Business Officer and Corporate Secretary)Marcus Cohn(Founder)

Co-investorsAglae VenturesAidenlair CapitalAliya Capital PartnersAllied Venture PartnersAlpha Wave GlobalAndreessen Horowitz+54 more

Meeshomeesho.comin𝕏NSE: MEESHOLate Stage

Meesho operates an online marketplace that connects small businesses and individual entrepreneurs with customers across India, offering logistics, payments, and support services to help sellers manage their operations.

E-commerceEnterprise SoftwareBengaluru, IN

Vidit Aatrey(CEO)inSanjeev Barnwal(CTO)inSanjeev Kumar(Executive Officer, Director)Jatin Mazalcar(Executive Officer)inSoumyajit Das(Product Engineer)in

BoardSumer Juneja(Director)in

Co-investorsB Capital GroupB4 CapitalElevation CapitalFJ LabsGood CapitalInvestopad+22 more

Outset Medicaloutsetmedical.cominNASDAQ: OM

Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers.

Enterprise SoftwareHardwareHealthtechMedical DevicesSan Jose, US

Nabeel Ahmed(Executive Officer)inMarc Nash(Executive Officer)inJohn Brottem(General Counsel)inLeslie Trigg(Chair and CEO)inJeff Mack(Executive Officer)inRenee Gaeta(Chief Financial Officer)in

Co-investorsThe Vertical GroupDurable Capital PartnersT. Rowe PriceWarburg Pincus

Parabilis Medicinesparabilismed.cominNASDAQ: PBLSJan 2026

Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules.

AI & Machine LearningBiotechDeep TechMedical Devices

Mathai Mammen(CEO, President and Chairman)in

Co-investorsARCH Venture PartnersCatalio Capital Management, LPForesite CapitalFrazier Life SciencesGeneral CatalystGV (Google Ventures)+9 more

Pelotononepeloton.comNASDAQ: PTONMay 2017

Peloton develops connected fitness equipment and a digital fitness app that delivers personalized workout classes and training guidance to home exercisers.

ConsumerHardwareWellness & FitnessNew York, US

Graham Stanton(Founder)John Foley(Founder)inHisao Kushi(Founder)inPeter Stern(Chief Executive Officer and President)inElizabeth Coddington(Chief Financial Officer)Nick Caldwell(Chief Product Officer)in

Co-investorsAnsa CapitalBlue CollectiveBullishCade VenturesCoatue ManagementFELIX CAPITAL+22 more

Seres Therapeuticsserestherapeutics.comin𝕏NASDAQ: MCRB

Seres Therapeutics is a clinical-stage biotechnology company developing therapies composed of rationally selected live bacterial consortia to treat serious diseases through modulation of the human microbiome.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Matthew Henn(President and Chief Scientific Officer)inJohn Aunins(Executive Officer)inEric D. Shaff(Executive Officer)inDavid Cook(Executive Officer)inRoger J. Pomerantz(Executive Officer, Director)inRichard N. Kender(Executive Chair and Interim Chief Executive Officer)

Co-investorsFlagship PioneeringRA CapitalSofinnova Ventures

Snapsnapchat.cominNYSE: SNAPMay 2016

Snapchat is a mobile app for communicating with friends and family through photos and videos, featuring augmented-reality Lenses, creative sharing tools, and a personalized map for discovering places and content.

ConsumerCreator EconomyMedia & EntertainmentSocialSanta Monica, US

Evan Spiegel(Founder)inBobby Murphy(Founder)Reggie Brown(Founder)Tim Sehn(Executive Officer)Emily White(Executive Officer)inDerek Andersen(Chief Financial Officer)in

Co-investorsA-Rod CorpAccess Technology VenturesAlibaba GroupCapitalGCoatue ManagementEntrée Capital+39 more

SpaceXspacex.comNASDAQ: SPCXJan 2015

Revolutionizing space technology to make life multi-planetary

Hawthorne, US

Elon Musk(Founder)inBret Johnsen(Executive Officer)inGwynne Shotwell(Executive Officer, Director)Tom Mueller(Founder)

BoardAntonio Gracias(Director)inSteve Jurvetson(Director)in

Co-investors1/1 Capital137 Ventures1802 Ventures2080 Ventures3Spoke Capital4DX Ventures+211 more

Spero Therapeuticssperotherapeutics.cominNASDAQ: SPRO

Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, led by SP001, a third-generation anti-CD40L antibody targeting IgG4-related disease.

BiotechCambridge, US

Ankit Mahadevia(Executive Officer, Director)inStephen Garbacz(Executive Officer)inEsther Rajavelu(Director, President, Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer)in

BoardJean-Francois Formela(Director)inReza Halse(Director)Casper Breum(Director)

Co-investorsGV (Google Ventures)HEALTHCARE ROYALTY PARTNERSMRL Ventures FundOUP (Osage University Partners)RA CapitalAlphabet+1 more

Voyager Therapeutics, Inc.voyagertherapeutics.comNASDAQ: VYGR

Voyager Therapeutics is a biotechnology company developing genetic medicines for neurological diseases of the central nervous system, including Alzheimer's disease, ALS, and Parkinson's disease.

BiotechHealthtechLexington, US

Todd Carter(Executive Officer)inRobin Swartz(Executive Officer)inAlfred Sandrock(Executive Officer, Director)Peter Pfreundschuh(Executive Officer)inNathan Jorgensen(Chief Financial Officer; Principal Financial Officer and Principal Accounting Officer)Steven Hyman(Director)

Co-investorsWellington ManagementARCH Venture PartnersThird Rock Ventures

Atom Ticketsatomtickets.comin𝕏Aug 2017 · $60M✓ verified

Atom Tickets operates a social movie ticketing app and website that lets moviegoers browse films, watch trailers, buy tickets, invite friends to purchase their own tickets, and pre-order concessions for pickup at the theater.

ConsumerMarketplacesMedia & EntertainmentSanta Monica, US

Ameesh Paleja(Co-Founder)inMatthew Bakal(President, Treasurer and Manager)inGeoff Shaevitz(Co-Founder)inAllison Checchi(Chief Operating Officer)in

BoardChris Aronson(Manager)Jennifer Hollingsworth(Manager)

Co-investorsCerity Partners Ventures

EDXMedxmarkets.comin𝕏✓ verified

EDX Markets operates a Singapore-based perpetual futures trading venue for digital assets, focused on competition, transparency, and safety in crypto markets.

Crypto & Web3FintechSingapore, SG

Co-investorsPantera CapitalVirtu FinancialGSR

Endeavor Biomedicinesendeavorbiomedicines.comin𝕏✓ verified

Endeavor BioMedicines is a biopharmaceutical company developing medicines aimed at treating patients with serious, intractable diseases, with the goal of altering disease progression rather than only slowing it.

BiotechSan Diego, US

John Hood(Co-Founder, Chief Executive Officer & Executive Chairman)inWing Cheong Lam(Director)Bernard Davitian(Director)Raghu Saripalli(Executive Officer)Monal Mehta(Director)inMiguel de los Rios(Co-Founder & Chief Scientific Officer)in

Co-investorsLongitude CapitalOmega Funds

Medical Micro Instrumentsmmimicro.comin𝕏Feb 2024✓ verified

MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.

HealthtechMedical DevicesRoboticsJacksonville, US

Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)

Co-investorsAndera PartnersBioStar CapitalDeerfield Management CompanyRA CapitalCorewell Health VenturesFountain Healthcare Partners

Silver Lakesilverlake.com✓ verified

Waymo develops the Waymo Driver, an autonomous vehicle system that provides ride-hailing services across multiple metropolitan areas.

AI & Machine LearningHardwareMobility & TransportationRoboticsSemiconductorsMountain View, US

Raghib Hussain(Chief Executive Officer)Tekedra MawakanaDmitri Dolgov

Co-investorsAlphabetAndreessen HorowitzBessemer Venture PartnersCapitalGDragoneer Investment GroupDST Global+9 more

119119-website.netlify.app

119 is a patent-pending mobile and wearable system that acts as a modern medical ID, communicating a user's medical information to bystanders or first responders via QR code and guiding them through the appropriate emergency response.

Digital HealthHardwareHealthtech

Jen(Founder)

Co-investorsJumpStart EquityACTivate CapitalBlackRockLightrockPrologis VenturesRedpoint Ventures+2 more

23andMe23andme.comin𝕏Jun 2015Acquired

23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityMountain View, US

Anne Wojcicki(Founder)inLinda Avey(Founder)Paul Cheung(Co-founder)Andrew Page(Executive Officer, Director)Kathy Hibbs(Executive Officer)inPaul Cusenza(Founder)

Co-investorsAdam NashAllied Venture PartnersBright Success CapitalCivilization Ventures Management, LlcEQUIAMFirebolt Ventures Management Company, Llc+18 more

Afferent PharmaceuticalsinJul 2015

BiotechSan Mateo, US

Anthony Ford(Executive Officer)inMichael Kitt(Executive Officer)inKathleen Sereda Glaub(Executive Officer, Director)in

BoardKevin Starr(Director)inArthur Pappas(Director)Liam Ratcliffe(Director)

Co-investorsPappas CapitalDomain AssociatesJennison AssociatesThird Rock Ventures

AgelessRxagelessrx.comin𝕏Aug 2026

AgelessRx offers prescription weight management medications delivered through a telehealth platform, including GLP-1 medications (semaglutide, tirzepatide), FDA-approved weight loss drugs (Wegovy, Zepbound), and supportive treatments like metformin and vitamin injections for adults seeking medically-supervised weight loss.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityAnn Arbor, US

Anar Isman(Co-Founder & Chief Executive Officer)inRobert Michael Pejovich(Director of Finance of the Issuer)

Co-investors1/1 Capitalabrdn plcAngelini VenturesJanus Henderson InvestorsSanofi Ventures

Agomab Therapeuticsagomab.cominOct 2023 · $100M

Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.

BiotechHealthtechMedical DevicesAntwerp, BE

Tim Knotnerus(Chief Executive Officer)in

Co-investorsEQT Life SciencesAdBio partnersAndera PartnersAsabys PartnersCanaan PartnersPontifax Venture Capital+1 more

Akouosakouos.comin

Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing.

BiotechHealthtechBrookline, US

Emmanuel Simons(Executive Officer, Director)william sewell(Founder)in

BoardEd Mathers(Director)inKush Parmar(Director)in

Co-investors5AM VenturesEcoR1 CapitalNew Enterprise Associates (NEA)Pivotal Life SciencesRA CapitalSofinnova Ventures+2 more

Aledadealedade.comin𝕏Jun 2023 · $260M

Aledade is an accountable care organization (ACO) partner that works with primary care organizations to improve patient outcomes and healthcare quality.

Enterprise SoftwareHealthtechBethesda, US

Bijan Salehizadeh(Co-founder)inFarzad Mostashari(Founder)inMat Kendall(Founder)in

BoardRobert Kocher(Director)in

Co-investorsActivate Venture PartnersARCH Venture PartnersEcho Health VenturesGV (Google Ventures)Intrepid Growth PartnersIVP (Institutional Venture Partners)+11 more

Algoliaalgolia.comin𝕏Jul 2021

Algolia provides an API platform that enables developers to integrate search and discovery functionality into websites and mobile applications, serving thousands of companies across e-commerce, media, and SaaS.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Nicolas Dessaigne(Board Member)inJulien Lemoine(CTO)inBernadette Nixon (CEO)(Founder)Gabriel Dillon(Senior Partner Sales Executive, Americas)Kristie Rodenbush(Chief People Officer)Zaviear Lue(Senior Manager, Recruiting)

Co-investors500 GlobalAccelAcequia Capital (AceCap)Aglae VenturesCollective LiquidityFounders Circle Capital+20 more

Ankyra Therapeuticsankyratx.comin𝕏Oct 2024

Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.

BiotechDeep TechHealthtechMedical DevicesAustin, US

Tillman Gerngross(Executive Officer, Director)

BoardTerrance McGuire(Director)

Co-investorsGV (Google Ventures)Mithril Capital ManagementPolaris PartnersSands Capital VenturesSpring Mountain Capital

Anthropicanthropic.comin𝕏Sep 2025 · $13B

Anthropic is an AI safety research company that builds reliable, interpretable, and steerable AI systems.

AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareSan Francisco, US

Dario Amodei(Founder)inDaniela Amodei(Founder)inTom Brown(Founder)inJack Clark(Founder)inJared Kaplan(Founder)inChris Olah(Founder)in

Co-investors3Comma Capital7BC Venture Capital7GC & CoA.Capital VenturesAccelAkka+151 more

Applied Intuitionappliedintuition.comin𝕏

Applied Intuition develops physical AI software for autonomous and intelligent machines, including vehicles, robots, ships, and satellites across industries like automotive, defense, logistics, and manufacturing.

AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareRoboticsSunnyvale, US

Qasar Younis(Founder)inPeter Ludwig(Founder)inQasar Younis Peter Ludwig(Founder)

Co-investors137 VenturesAndreessen HorowitzBond Capital ManagementCatalytic Impact FoundationCoatue ManagementElad Gil+33 more

ApplyBoard Inc.applyboard.cominJan 2021

ApplyBoard operates a platform connecting international students with educational institutions across Canada, the US, UK, Ireland, Australia, and Germany.

AI & Machine LearningB2B MarketplacesEdTechMarketplacesSaaSLondon, CA

Meti Basiri(Founder)inMartin Basiri(Founder)inMassi Basiri(Founder)in

Co-investors500 GlobalArtiman VenturesBDC Growth Venture FundCandou VenturesCeltic House Asia PartnersDrive Capital+13 more

Astranisastranis.comin𝕏Series C · May 2026 · $300M

Astranis manufactures small, high-powered geosynchronous satellites equipped with advanced digital processing technology for global telecommunications and connectivity services.

Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US

John Gedmark(CEO)inRyan McLinko(CTO)inMike Mancini(Executive Officer)Siamak Ebadi(Lead RF Engineer)inHall Chen(RF Payload Design)inShraddha Pandya(Talent Acquisition)

Co-investorsAndreessen HorowitzATEL VenturesBlack FlagBoxGroupCantos VenturesCherubic Ventures+85 more

Bain Capital Special Situationsbaincapitalspecialsituations.comin𝕏May 2025 · $2.1B

Bain Capital Special Situations is a private investment firm that combines private equity, private credit, and asset-backed capital to source and structure specialized deals across asset classes.

FintechSector AgnosticHong Kong, HK

Co-investorsBain CapitalBain Capital Double Impact Fund LPBain Capital Life SciencesBain Capital Tech OpportunitiesGallatin Point Capital

Benchlingbenchling.comin𝕏Apr 2016

Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.

AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US

Sajith Wickramasekara(CEO)inAshutosh Singhal(Founder)Ashu Singhal(Founder)inCheng Kang(Founder)Cornelius Chen(Founder)Cory Liin

Co-investorsAlkeon InnovationAndreessen HorowitzArtisanal VenturesBalaji SrinivasanDraper AssociatesEnsemble Labs+31 more

Boltbolt.euin𝕏

Bolt operates a European mobility super-app offering ride-hailing, shared cars, e-scooters, and food and grocery delivery, along with on-demand parcel delivery.

Logistics & Supply ChainMarketplacesMobility & TransportationTallinn, EE

Eric Feldman(Founder)Markus Villig(Founder)Martin Villig(Founder)Oliver Leisalu(Founder)Ryan Breslow(Founder)

Co-investorsAkkaBADideas.fundCSVE Venture PartnersG SquaredKorelya CapitalPejoni+23 more

Bolt Threadsboltthreads.comDefunct

Bolt Threads was a manufacturer of biomaterials for personal care formulations.

BiotechNew MaterialsFoxboro, US

Ethan Mirsky(Founder)David Breslauer(Founder)Daniel Widmaier(Executive Officer, Director)Dan Widmaier(Founder)

BoardJerry Fiddler(Director)Steven Vassallo(Director)in

Co-investorsKicker VenturesKyber Knight CapitalMission Bay CapitalMission Biocapital8VCBaillie Gifford+6 more

Boostedboosted.aiinNov 2024 · $15M

Boosted.ai provides an AI platform for investment research that answers questions on stocks and themes and uses AI agents to generate reports and analysis for investment professionals.

AI & Machine LearningFintechSaaS

Joshua Pantony(Founder)inJon Dorando(Founder)in

Co-investorsDunamu & PartnersPortage VenturesRBCxHarbourVest Partners (Canada)Spark CapitalTen Coves Capital

Boweryboweryfarming.comMay 2021Defunct

Bowery Farming uses controlled environment agriculture to grow fresh produce locally in urban centers.

AgTechFoodTechNew York, US

Irving Fain(Founder)inChristopher Livingston(Executive Officer)Darren Thompson(Executive Officer)inBrian Falther(Founder)David Golden(Founder)

BoardAndy Wheeler(Director)

Co-investorsEvolution VC PartnersHomebrewRed Swan VenturesRRE VenturesSand Hill AngelsSV Angel+11 more

Bright Peak Therapeuticsbrightpeaktx.cominJun 2021

Bright Peak Therapeutics is a biotechnology company developing multi-functional PD-1 inhibitors for cancer immunotherapy, based on its EDC protein-engineering platform.

BiotechHealthtechSan Diego, US

Vijaya Pattabiraman(Co-founder & Chief Technology Officer)inJeffrey Bode(Scientific co-founder)inFredrik Wiklund(Chief Executive Officer)Christine Siu(Director)Michael Rosenzweig(Director)Bertolt Kreft(Executive Officer)

Co-investorsRA CapitalJohnson & Johnson Innovation – JJDCVersant VenturesVenrockAlexandriaBlackRock+2 more

Cardurioncardurion.cominJul 2024 · $260M

Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBurlington, US

Michael E. Mendelsohn(Founder and Chief Strategy Officer)in

Co-investorsBain CapitalAscenta CapitalDelos CapitalDigitalis VenturesNew Enterprise Associates (NEA)Bain Capital Life Sciences+4 more

Castle Creek Biosciencescastlecreekbio.comin𝕏May 2022 · $112.8M

Castle Creek Biosciences develops re-dosable gene therapies for genetic diseases, with a lead candidate (D-Fi) in registrational clinical trials for dystrophic epidermolysis bullosa.

BiotechDeep TechMedical DevicesExton, US

Matthew Gantz(President and Chief Executive Officer)inDavid ChuinMichael TownsleyChristopher J. LarsoninRhea WilliamsinJude Sullivan(Executive Officer)

Co-investorsParagon Biosciences LLCValor Equity PartnersHorizon

Celestial AIcelestial.aiin𝕏Mar 2025 · $250M

The page describes Photonic Fabric, an optical interconnect technology platform for the scale-up interconnect market that enables high-bandwidth, power-efficient links for AI data center infrastructure.

AI & Machine LearningDeep TechSector AgnosticSemiconductorsSanta Clara, US

Preetinder Virk(Chief Operating Officer)David Lazovsky(Founder)inKelyn Brannon(Chief Financial Officer)Philip Winterbottom(Chief Technology Officer)inDave Lazovsky(Founder)Preet Virk(Founder)

Co-investorsFitz Gate VenturesIAG Capital Partnersimec.xpandKoch Disruptive TechnologiesM VenturesSamsung Catalyst Fund+11 more

CFO.airunway.comin𝕏Feb 2026 · $315M

Runway helps founders understand financial data and spreadsheets.

AI & Machine LearningEnterprise SoftwareFintechSaaS

Anastasis Germanidis(Founder)inCristóbal Valenzuela(Founder)inSiqi Chenin

BoardDylan FieldHenry Ward

Co-investors500 GlobalAndreessen HorowitzChamaeleonCrosscourt VenturesDreamers VCInitialized Capital+9 more

Checkrcheckr.comin𝕏Late Stage · Sep 2021 · $250M

Checkr provides background verification and fraud detection services for hiring, loan approvals, insurance, and tenant screening decisions.

AI & Machine LearningEnterprise SoftwareHR TechSaaSSan Francisco, US

Daniel Yanisse(CEO)inJonathan Perichon(Founder)inNaeem Ishaq(Executive Officer)inJennifer Yeh(Executive Officer)inTodd Freedman(Executive Officer)inChris Hollindale(Head of Checkr Pay)in

Co-investorsAccelActivant CapitalBond Capital ManagementCoatue ManagementDCVC (Data Collective)Earl Grey Capital+22 more

City Therapeuticscitytx.comin𝕏Oct 2024

City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.

BiotechMedical DevicesCambridge, US

Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)Andy Orth(Chief Executive Officer)in

Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesViking GlobalAltitude Ventures Management, LlcCasdin Capital+5 more

Codiakbiocodiakbio.comFeb 2021

Cambridge, MA clinical-stage biotech developing engineered exosome therapeutics; IPO'd on NASDAQ in 2020, later restructured.

BiotechSeattle, US

Doug Williams(Executive Officer, Director)in

BoardNoubar Afeyan(Director)inSteven Gillis(Director)Eric Lander(Director)

Co-investorsARCH Venture PartnersEcoR1 CapitalAlexandriaFlagship PioneeringQatar Investment Authority

Coin Metricscoinmetrics.ioin𝕏Mar 2022

Coin Metrics provides market and on-chain data, reference rates, and indexes for crypto and digital assets, delivered to institutional investment teams via APIs.

Crypto & Web3Data & InfrastructureFintechBoston, US

Tim Rice(Founder)inAleksei Nokhrin(Founder)Alexander Bich(Founder)Jacob Franek(Founder)

BoardMathew S. McDermott(Director)Sean Judge(Director)in

Co-investorsAcrew CapitalBlockchain CoinvestorsCoinbase VenturesCollab+CurrencyCommunitas Capital PartnersDigital Currency Group+10 more

CollegeVinecollegevine.comApr 2019 · $24M

AI agent platform for universities to streamline workflows.

Johan Zhang(Founder)Jon Carson(Founder)Vinay Bhaskara(Founder)Zachary Perkel(Founder)

Co-investorsMenlo VenturesSilversmith Capital Partners

Corastonecorastone.usin

Corastone provides infrastructure that converts private market investments into digital asset securities, offering automated straight-through processing, a unified investment lifecycle, and blockchain-based transaction processing.

Crypto & Web3Enterprise SoftwareFintechSaaS

Hamid Gayibov(Founder)in

Co-investorsMotive PartnersApolloFranklin TempletonHamilton Lane

CoreWeavecoreweave.comin𝕏Jun 2024 · $7.5B

CoreWeave operates an AI-native cloud platform built to run large-scale AI workloads, combining GPU infrastructure, tooling, and support.

AI & Machine LearningCloud ComputingData & Infrastructure

Michael Intrator(Founder)inBrannin McBee(Founder)Brian Venturo(Founder)Peter Salanki(Founder)

Co-investorsCisco InvestmentsCoatue ManagementDragon CapitalFOG VenturesG SquaredHustle Fund+17 more

creditascreditas.comin𝕏Jan 2022 · $260M

Creditas is a Brazilian financial platform offering secured loans (using vehicles or real estate as collateral), payroll loans, auto and home financing, insurance, and flexible employee benefits.

ConsumerFintechInsurTech

Sergio Furio(Founder)inPavel Hubáček(Founder)

Co-investors1CrowdAmadeus Capital PartnersHeadlineHeadline Growth Management, LLCKaszek VenturesLightrock+15 more

Databricksdatabricks.comin𝕏Sep 2025

Databricks provides a unified platform for data engineering, analytics, and artificial intelligence, enabling organizations to build and deploy data and AI applications on cloud infrastructure.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareSan Francisco, US

Ali Ghodsi(Founder)inIon Stoica(Founder)inMatei Zaharia(Founder)inReynold Xin(Founder)inPatrick Wendell(Founder)inAndy Konwinski(Founder)in

Co-investors137 VenturesA.Capital VenturesAglae VenturesAlkeon InnovationAlpha Square GroupAltra Venture+115 more

Dermiradermira.com

HealthtechMenlo Park, US

Thomas G. Wiggans(Executive Officer, Director)inEugene A. Bauer(Executive Officer, Director)Andrew Guggenhime(Executive Officer)Luis Pena(Executive Officer)Christopher Griffith(Executive Officer)

BoardFred Craves(Director)in

Co-investorsAisling CapitalBay City CapitalCanaan PartnersForesite CapitalNew Enterprise Associates (NEA)Qiming Healthcare+1 more

Discorddiscord.comin𝕏Sep 2021

Discord is a communications platform for voice, video, and text chat designed primarily for gaming communities and players.

ConsumerCreator EconomyGamingSocialSan Francisco, US

Jason Citron(Founder)inStanislav Vishnevskiy(Founder)inClint Smith(Executive Officer)inHumam Sakhnini(Chief Executive Officer)Tomasz Marcinkowski(Chief Financial Officer)inBen Shanken(VP of Product)in

Co-investors1024 Venture1435 Capital1802 VenturesAccelAccess IndustriesAccess Technology Ventures+45 more

Emalexemalex.com𝕏Mar 2021 · $35M

Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, with a lead investigational asset, ecopipam, a selective dopamine D1 receptor antagonist for pediatric Tourette syndrome.

BiotechDigital Health

Co-investorsParagon Biosciences LLCValor Equity PartnersBain Capital Life Sciences

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Aristea TherapeuticsCastle Creek PharmaceuticalsMenlo MicrosystemsPronutria BiosciencesValenzaBioYumanity Therapeutics

Exits · 28

23 IPOs · 5 acquisitions · showing 21

Adagio TherapeuticsNASDAQ: IVVDAtara BiotherapeuticsNASDAQ: ATRACerebras SystemsNASDAQ: CBRSClarivateNYSE: CLVTDoorDashNASDAQ: DASHFate TherapeuticsNASDAQ: FATEFigmaNYSE: FIGInstacartNASDAQ: CARTIntellia TherapeuticsNASDAQ: NTLALyftNASDAQ: LYFTMeeshoNSE: MEESHOOutset MedicalNASDAQ: OMParabilis MedicinesNASDAQ: PBLSPelotonNASDAQ: PTONSeres TherapeuticsNASDAQ: MCRBSnapNYSE: SNAPSpaceXNASDAQ: SPCXSpero TherapeuticsNASDAQ: SPROVoyager Therapeutics, Inc.NASDAQ: VYGRErisXacq. by Cboe Global MarketsxAIacq. by SpaceX

Portfolio news

latest coverage across their companies

IPO stake values · per SEC filings · 7

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Clarivate7.8%$22.50Jun 2020$676.3M
Atara Biotherapeutics4.8%$52.00Jul 2015$70.1M
Seres Therapeutics6.5%$18.00Jun 2015$44.4M
Intellia Therapeutics5.3%$18.00May 2016$33.3M
Voyager Therapeutics, Inc.6.0%$14.00Nov 2015$22M
Fate Therapeutics15.0%$6.00Oct 2013$17.2M
Spero Therapeutics4.4%$12.50Jul 2018$10M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has Fidelity Investments made?
Fidelity Investments has 136 tracked investments, 28 of which have exited, including 41 dated in the last 24 months.
What sectors does Fidelity Investments focus on?
Fidelity Investments focuses on Crypto & Web3.
Where is Fidelity Investments located?
Fidelity Investments is headquartered in Boston, US.
Does Fidelity Investments lead rounds?
Fidelity Investments has led 33 of the 84 rounds where its role is on record.
Who does Fidelity Investments co-invest with?
Fidelity Investments most often shares deals with Coatue Management, IVP (Institutional Venture Partners), General Catalyst, among 90 tracked co-investors.

Media · Podcasts & interviews

from their channel

How Active Trader Pro Users Can Get Started with Fidelity Trader+® | Fidelity Investments

Fidelity Investments

Will New Rules Help Or Hurt Bitcoin? | Covering Crypto | Fidelity Investments

Fidelity Investments

The Biggest ETF Trends Investors Should Know Now | Market Sense | Fidelity Investments

Fidelity Investments

When Will Oil Prices And Inflation Go Down? - 9/17/26 | In The Money | Fidelity Investments

Fidelity Investments

The Best Time To Buy Bonds In Years? | Market Sense | Fidelity Investments

Fidelity Investments

A Closer Look At The Costs Of Long Term Care | Insights Live℠ | Fidelity Investments

Fidelity Investments

Images

Fidelity Investments photo

Similar investors

Featured in lists